The neuroendoscopy devices market is expected to reach USD 203.9 million by 2025. The global market is set to witness a higher CAGR in the forthcoming period. The neuroendoscopy devices market is driven by factors such as the rising number of cases of brain tumors and demand for minimally invasive surgeries. In addition, increasing incidences of intraventricular hemorrhage and growth in cases of pituitary tumors are likely to contribute to the market growth in the forecast period. The market witnesses several opportunities in form of rising incidences of brain injury and neural surgeries combined with an increase in minimally invasive procedures.
Endoscopy plays a crucial role in minimally invasive neurosurgery; and in fact, neuro endoscopy has undergone constant changes following the progress of rigid endoscopes, flexible and steerable fiberscopes. Neuroendoscopic techniques enable neuro-surgeons to achieve intraventricular cystic lesions in a minimally invasive technique. Determining the operative morbidity and mortality by using conventional approaches to the lesions, endoscopic surgery offers a safer outcome owing to the direct inspection of cyst membrane and regularity in contents. Combining neuroendoscopy with neuronavigation, the inclination towards robotic technology leads further to the progress in intraventricular neuroendoscopy.
The neuroendoscopy devices market is quadfurcated into surgery, device type, application, and geography. Geographical segmentation for the market spans North America, South America, Europe, Asia-Pacific, Middle East, and Africa. North American market is expected to lead the market growth in the forthcoming period followed by Europe. North America witnesses rising incidences of pituitary tumors that demand minimal invasive techniques for rapid recovery in patients. Favorable reimbursements, the rising prevalence of cancer, and a rise in investments are likely to fuel market growth shortly.
Asia-Pacific’s market is expected to gain positive traction in the forthcoming period due to untapped potential in the APAC sector and favorable opportunities in Japan, China, and India. In addition, healthcare insurance, a rise in technological advancements, and a rise in healthcare expenditure are likely to contribute to the market growth. The European market is expected to gain a moderate CAGR in the forthcoming period due to rising cases of premature births and improved healthcare infrastructure is likely to propel the market growth in the forthcoming period.
Middle Eastern regions are expected to gain higher growth in the forthcoming period owing to improvisation in maternal care solutions and the availability of enhanced NICU infrastructure. African regions are expected to register a moderate CAGR in the forthcoming period due to low awareness among the population regarding health policies by the government. In addition, growing cases of infection caused in people resulting in blood loss are likely to hinder the market growth.
However, opportunities such as technological advancements and a preference for minimally invasive diagnostics are likely to contribute to the neuroendoscopy devices market growth shortly. The key players in the neuro endoscopy devices industry include B.Braun Medical Inc, Olympus Corporation, Karl Storz, Zeiss International, Medtronic, and Stryker.
Market Segment:
Neuroendoscopy Devices Surgery Type Outlook (Revenue, USD Million; 2014 - 2025)
• Intraventricular
• Transcranial
• Transnasal
Neuroendoscopy Devices Type Outlook (Revenue, USD Million; 2014 - 2025)
• Rigid
• Flexible
Neuroendoscopy Devices Application Outlook (Revenue, USD Million; 2014 - 2025)
• Hospitals
• Medical Research Centers
Neuroendoscopy Devices Regional Outlook (Revenue, USD Million; 2014 - 2025)
• North America
• the U.S.
• Canada
• Europe
• Germany
• the UK
• the Asia Pacific
• Japan
• China
• Latin America
• Mexico
• Brazil
• MEA
• South Africa
Research Support Specialist, USA